Please use this identifier to cite or link to this item:
http://hdl.handle.net/11054/1793
Title: | Associations between DAPT score and long-term mortality post PCI. |
Author: | Tan, M. Dinh, D. Gayed, D. Liang, D. Brennan, A. Duffy, S. Clark, D. Ajani, A. Oqueli, Ernesto Roberts, L. Reid, C. Freeman, M. Chandrasekhar, J. |
Issue Date: | 2021 |
Conference Name: | 69th CSANZ Annual Scientific Meeting 43rd Annual Scientific Meeting of the International Society for Heart Research ANZET 21 |
Conference Date: | August 4-7 |
Conference Place: | Online |
Abstract: | Introduction: The dual antiplatelet (DAPT) score was developed to identify patients more likely to derive benefit (score ≥2) or harm (score <2) from DAPT beyond 1-year post PCI. We sought to examine long-term mortality after PCI by the DAPT score in patients treated with DAPT per local guidelines. Methods: We examined data from the MIG PCI database from 2005 to 2018 in whom the DAPT score could be derived and grouped them as score ≥2 or <2. Long-term mortality was assessed from National Death Index linkage. The primary endpoint was long-term mortality examined using survival analysis. Secondary endpoints included 30-day ischaemic outcomes and in-hospital major bleeding. Results: Out of 27,740 patients in the study, 9,401 (33.9%) had DAPT score ≥2. They were younger and included more females and higher prevalence of renal impairment. DAPT score ≥2 patients had higher in-hospital major bleeding, 30-day mortality, MI and target vessel revascularisation. DAPT score ≥2 patients had lower long-term survival to 12 years (p<0.001 for all). Conclusion: A third of all-comer PCI patients had DAPT score ≥2 with greater short-term risk of ischaemic and bleeding outcomes, as well as long-term mortality. Theoretically, those with DAPT score ≥2 would benefit from longer duration of DAPT as ischaemic risk outweighs bleeding risk. However, given our finding of increased short-term bleeding risk and long-term mortality, dynamic bleeding risk assessment should be undertaken to guide pharmacotherapy strategies. |
URI: | http://hdl.handle.net/11054/1793 |
Internal ID Number: | 01756 |
Health Subject: | DUAL ANTIPLATELET CARDIOLOGY PCI PERCUTANEOS CORONARY INTERVENTION |
Type: | Conference Paper |
Appears in Collections: | Research Output |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.